Sprout Capital IX, L.P. (Healthcare Technology Portfolio) $ amounts in millions, as of March 31, 2014 Please refer to Endnotes L],.K,L,M and N in this Appendix. Gross Multiple Gross Vintage Total Realized Unrealized Total (Realized Multiple Company Sector Year Cost Value Value Value Portion) (Total) Gross IRR Adolor Corporation Therapeutics 2000 $ 293 §$ 23.5 § - $ 23.5 0.80 0.80 42% Affymax, Inc. Therapeutics 2001 $ 37.2 $ 17.9 $ - $ 17.9 0.48 0.48 -11.3% Aspire Medical Healthcare Devices 2004 $ 7A $ 0.6 $ . $ 0.6 0.07 0.07 NM Aspreva Pharmaceuticals Therapeutics 2004 $ 23.2 $ 151.7 $ - $ 151.7 6.54 6.54 95.4% Aureon Biosciences, Inc. Diagnostics & Infrastructure 2001 $ 341 $ 08 $ = $ 0.8 0.02 0.02 NM Auxilium Pharmaceuticals, Inc. Therapeutics 2003 $ 231 $ 1063 $ - $ 106.3 4.60 4.60 37.4% Corixa Corporation Therapeutics 2003 $ 42.7 §$ 31.1 $ - $ 31.1 0.73 0.73 -13.2% eHealth, Inc. Convergence 2001 $ 121 $ 58.4 $ - $ 58.4 4.83 4.83 26.8% Epicor Medical, Inc. Healthcare Devices 2001 $ 93 § 41.8 $ - $ 41.8 4.49 4,49 78.7% ePocrates, Ine. Convergence 2000 $ 172 §$ 53.2 $§$ - $ 53.2: 3.10 3.10 10.8% Focus Technologies, Inc. Diagnostics & Infrastructure 2000 $ 32.3 $ 84.1 $ - $ 84.1 2.61 2.61 17.8% Gryphon Therapeutics Therapeutics 2002 $ 13.3 $ 0.2 $ - $ 0.2 0.01 0.01 -60.7 % Ilypsa, Inc. (fka Symyx) Therapeutics 2003 §$ 158 $ 109.4 $ - $ 109.4 6.91 6.91 78.0% ISTA Pharmaceuticals, Inc. Therapeutics 2002 $ 429 § 84.6 $ - $ 84.6 1.97 1.97 10.8% Kalypsys Therapeutics 2002 $ 274 §$ 11° $ - $ 1.1 0.05 0.04 -29.7% Lathian Systems, Inc Convergence 2001 $ 71 $ 0.0 6 6$ = $ 0.0 0.00 0.00 NM Metabasis Therapeutics, Inc. Therapeutics 2001 $ 238 $ 11 $ Z $ 1.1 0.05 0.05 NM NeuroVista Corp. Healthcare Devices 2004 $ 88 ¢ = $ = $ = - - NM NxStage Medical, Inc. Healthcare Devices 2001 $ 216 $ 45.1 $ - $ 45.1 2.09 2.09 94% Nyco Holdings ApS Therapeutics 2002 $ 470 $ 2228 § 2.7 $ 225.5 4.74 4.80 33.6% Pharsight Corporation Convergence 2002 $ 28 §$ 64 $ - $ 6.4 2.31 2.31 16.2% Phylo